Recent Articles from Benzinga
Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Website: https://www.benzinga.com
Bitcoin's (CRYPTO: BTC)
Via Benzinga · November 17, 2025
Shares of Apple Inc. (NASDAQ: AAPL) are trading lower on Monday. Here's a look at what investors need to know.
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Wall Street obsesses over NVDA Vs AMD rivalry but NVDA's earnings reveal a different story. NVDA's growth and commitments dwarf competition.
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Repare Therapeutics agrees to be acquired by XenoTherapeutics, offering shareholders cash, CVRs, and future milestone potential as the deal targets an early 2026 closing.
Via Benzinga · November 17, 2025
Palantir expands AI footprint through partnerships with FTAI Aviation and NHS, utilizing its AI platform to enhance performance and training.
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
YMM beats revenue expectations with $471.7M in Q3 sales, but lower operating income triggers a premarket sell-off. Outlook shows double-digit growth.
Via Benzinga · November 17, 2025
FDA accepts NDA for Celcuity's advanced breast cancer therapy. Analyst downgrades stock due to high valuation. Next catalyst is topline data.
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Novo Nordisk's new chair Lars Sorensen plans to add pharma expertise and address governance concerns after a major board overhaul backed by the company's foundation.
Via Benzinga · November 17, 2025
Tonix Pharmaceuticals shares are rising Monday morning after the company announced the U.S. commercial availability of its new drug, TONMYA.
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Alibaba is driving value by launching a free Qwen AI app for chat, navigation, shopping, and productivity tools. It also slashes prices for its AI models.
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Aramark's stock (ARMK) fell after reporting lower fourth-quarter FY25 earnings, with revenue missing analyst estimates.
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Magnificent Seven, beware. Kai Wu says Wall Street's AI darlings are shifting toward a riskier, capital-heavy model.
Via Benzinga · November 17, 2025
Quantum Computing Inc shares are rising on Monday after the company announced better-than-expected financial results for the third quarter.
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Cardano (CRYPTO: ADA) is struggling after a brutal 20% one-week drop, even as Charles Hoskinson rallies the community with calls for a "gigachad bullr
Via Benzinga · November 17, 2025
Bitcoin (CRYPTO: BTC) is down 30% from its all-time high, but the nature of the decline points to a structural, mechanical breakdown rather than a
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Tariffs may shape inflation far differently than standard economic models predict, according to a new working paper from two San Francisco Fed researchers. Their findings suggest the impact of trade barriers is more complex than previously understood.
Via Benzinga · November 17, 2025
Carl Icahn's hedge fund Q3 portfolio reshuffle: $9.14B, concentrated, contrarian. Walked away from Bausch Health, added EchoStar.
Via Benzinga · November 17, 2025
Niu Technologies (NIU) stock rose after reporting strong Q3 results, with revenue up 65.4% Y/Y. China sales grew 74.2%.
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025
Via Benzinga · November 17, 2025